Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.18 USD
Change Today -0.0173 / -8.69%
Volume 135.3K
HEB On Other Exchanges
Symbol
Exchange
NYSE Amex
Frankfurt
As of 9:34 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for hemispherx biopharma inc (HEB)

Year over year, Hemispherx Biopharma, Inc. has seen their bottom line shrink from a loss of $16.2M USD to an even larger loss of $17.5M USD despite an increase in revenues from $150.0K USD to $197.0K USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues0.20.20.20.2
TOTAL REVENUES0.20.20.20.2
Cost of Goods Sold1.02.01.21.3
GROSS PROFIT-0.9-1.8-1.1-1.1
Selling General & Admin Expenses, Total6.79.17.79.1
R&D Expenses6.69.58.28.5
OTHER OPERATING EXPENSES, TOTAL13.318.515.917.6
OPERATING INCOME-14.1-20.3-17.0-18.7
Interest Expense0.00.00.00.0
Interest and Investment Income0.61.60.80.7
NET INTEREST EXPENSE0.61.60.80.7
Other Non-Operating Income (Expenses)4.71.41.01.1
EBT, EXCLUDING UNUSUAL ITEMS-8.9-17.3-15.2-16.9
Gain (Loss) on Sale of Investments--0.0-0.8-0.1
Other Unusual Items, Total-0.10.0-0.2-0.4
EBT, INCLUDING UNUSUAL ITEMS-9.0-17.4-16.2-17.4
Earnings from Continuing Operations-9.0-17.4-16.2-17.4
NET INCOME-9.0-17.4-16.2-17.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-9.0-17.4-16.2-17.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-9.0-17.4-16.2-17.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HEB:US $0.19 USD -0.0108

HEB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Allergan plc $307.37 USD -0.143
AstraZeneca PLC 4,153 GBp -14.00
Baxter International Inc $38.00 USD -0.30
Medigene AG €11.33 EUR +1.00
Sarepta Therapeutics Inc $29.57 USD -0.57
View Industry Companies
 

Industry Analysis

HEB

Industry Average

Valuation HEB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 270.8x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 186.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEMISPHERX BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.